Product Certification&
    Enterprise Certification

  • Mr.chen
    Tel: +86-25-83208295

  • Mobile:+86-18913388297
  • Tel:+86-25-83208295
  • Fax:+86-25-83208202
  • Province/state:jiangsu
  • City:nanjing
  • Street:B-313,No.26,Fu Hou Gang,Gu Lou District, Nanjing 210009,China
  • MaxCard:
Home > Products >  Ceftizoxime sodium injection supplier in China

Ceftizoxime sodium injection supplier in China CAS NO.68401-82-1

  • Min.Order: 0 Metric Ton
  • Payment Terms:
  • Product Details

Keywords

  • Ceftizoxime sodium supplier
  • Ceftizoxime sodium China
  • Ceftizoxime sodium injection

Quick Details

  • ProName: Ceftizoxime sodium injection supplier ...
  • CasNo: 68401-82-1
  • Molecular Formula: C13H12N5NaO5S2
  • Appearance: powder
  • Application: API
  • PackAge: 7.5KG
  • Port: shanghai
  • ProductionCapacity: Metric Ton/Day
  • Purity: 98%
  • Storage: Room temperature
  • Transportation: ordinary goods
  • LimitNum: 0 Metric Ton

Superiority

High quality product, competitive price and best service.

Details

1. Introduction of Diethyl fluoromalonate 

Diethyl fluoromalonate with the CAS registry number 68401-82-1, is also known as 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-, monosodiumsalt, (6R,7R)-. Its systematic name is sodium (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate. Its classification codes are: (1)Antibacterial; (2)Antibiotics; (3)Drug / Therapeutic Agent; (4)Reproductive Effect.


2. Basic Information of Diethyl fluoromalonate 

It is a semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms.

1) Properties

Physical properties of Diethyl fluoromalonate is: (1)ACD/LogP: 0.59; (2)# of Rule of 5 Violations: 1; (3)#H bond acceptors: 10; (4)#H bond donors: 4; (5)#Freely Rotating Bonds: 5; (6)Polar Surface Area: 169.18 ?2.

 

2) Descriptors of Structure
You can still convert the following datas into molecular structure:
(1)SMILES: [Na+].O=C2N1/C(=C\CS[C@@H]1[C@@H]2NC(=O)C(=N\OC)/c3nc(sc3)N)C([O-])=O
(2)Std. InChI: InChI=1S/C13H13N5O5S2.Na/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18;/h2,4,8,11H,3H2,1H3,(H2,14,15)(H,16,19)(H,21,22);/q;+1/p-1/b17-7-;/t8-,11-;/m1./s1
(3)Std. InChIKey: ADLFUPFRVXCDMO-LIGXYSTNSA-M


3) Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo intravenous > 3200mg/kg (3200mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

CARDIAC: CARDIOMYOPATHY INCLUDING INFARCTION
Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 1669, 1980.
 
mouse LD50 intraperitoneal 8930mg/kg (8930mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 1669, 1980.
mouse LD50 intravenous 5150mg/kg (5150mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 24, Pg. 905, 1982.
mouse LD50 oral > 10gm/kg (10000mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 1669, 1980.
mouse LD50 subcutaneous > 10gm/kg (10000mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 1669, 1980.
rabbit LDLo intravenous > 3200mg/kg (3200mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 1669, 1980.
rabbit LDLo oral > 3200mg/kg (3200mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 1669, 1980.
rat LD50 intraperitoneal 8130mg/kg (8130mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 1669, 1980.
rat LD50 intravenous 5570mg/kg (5570mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 1669, 1980.
rat LD50 oral > 10gm/kg (10000mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 1669, 1980.
rat LD50 subcutaneous > 10gm/kg (10000mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 1669, 1980.

 

 

4) Side effects

Ceftizoxime may cause side effects. If you are administering ceftizoxime into a muscle, it may be mixed with lidocaine (Xylocaine) to reduce pain at the injection site. Tell your health care provider if any of these symptoms are severe or do not go away: stomach pain; upset stomach; vomiting.

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog